Status:

NOT_YET_RECRUITING

'Inner Ear Support' Oral Capsule in Patients With Sudden Sensorineural Hearing Loss

Lead Sponsor:

Far East Bio-Tec Co., Ltd

Conditions:

Sudden Sensorineural Hearing Loss (SSNHL)

Tinnitus

Eligibility:

All Genders

18-75 years

Phase:

NA

Brief Summary

Sudden sensorineural hearing loss (SSNHL) is a medical condition where people experience rapid hearing loss, usually in one ear, over a short period of time (typically within 72 hours). It can affect ...

Detailed Description

Sudden sensorineural hearing loss (SSNHL) is an otologic emergency characterized by rapid onset of hearing loss, typically unilateral, occurring over less than 72 hours. The annual incidence is estima...

Eligibility Criteria

Inclusion

  • Patients aged between 18 and 75 years
  • Patients diagnosed with sudden sensorineural hearing loss as determined by the principal or sub-investigator
  • Average hearing threshold in the affected ear ≥ 60 dB
  • Initiation of treatment within two weeks of hearing loss onset

Exclusion

  • Patients with congenital or hereditary hearing loss
  • Patients with fluctuating hearing loss
  • Patients currently participating in other interventional treatments for sudden hearing loss
  • Patients who have undergone surgery on the affected ear
  • Patients with neurological or psychiatric disorders
  • Patients with heart failure or ischemic heart disease
  • Patients with immunodeficiency
  • Patients with vestibular schwannoma (acoustic neuroma)
  • Patients with other internal medical conditions deemed by the investigator to potentially interfere with the study conduct or outcomes
  • Pregnant patients
  • Patients with a known allergy to the investigational product
  • Patients currently using acetylcysteine or products containing ginkgo biloba extract
  • Patients with autoimmune diseases or currently receiving immunosuppressive therapy

Key Trial Info

Start Date :

June 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 30 2026

Estimated Enrollment :

80 Patients enrolled

Trial Details

Trial ID

NCT06997406

Start Date

June 1 2025

End Date

June 30 2026

Last Update

May 30 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Taiwan University Hospital

Taipei, Taiwan